Quadrant Capital Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$100K Buy
3,192
+1,362
+74% +$42.9K ﹤0.01% 1481
2025
Q4
$53.9K Buy
1,830
+235
+15% +$6.53K ﹤0.01% 1658
2025
Q3
$40.3K Buy
+1,595
New +$38.9K ﹤0.01% 1746
2025
Q2
Sell
-535
Closed -$12.3K 2345
2025
Q1
$12.3K Sell
535
-2,043
-79% -$49.3K ﹤0.01% 2169
2024
Q4
$65.3K Sell
2,578
-2,051
-44% -$52K ﹤0.01% 1274
2024
Q3
$115K Sell
4,629
-884
-16% -$26.2K 0.01% 992
2024
Q2
$163K Buy
5,513
+1,417
+35% +$39.3K 0.01% 750
2024
Q1
$123K Buy
4,096
+73
+2% +$2.03K 0.01% 888
2023
Q4
$115K Buy
4,023
+278
+7% +$8.16K 0.01% 914
2023
Q3
$139K Sell
3,745
-39
-1% -$1.49K 0.01% 698
2023
Q2
$148K Buy
3,784
+80
+2% +$3.13K 0.01% 659
2023
Q1
$135K Buy
3,704
+496
+15% +$15.7K 0.01% 677
2022
Q4
$98.8K Buy
+3,208
New +$99.6K 0.01% 778

Other funds holding RTO

Quadrant Capital Group's RTO Position: Q1 2026 in Review

Quadrant Capital Group increased its Rentokil (RTO) stake by 74% in Q1 2026, buying an estimated $42.9K and bringing the position to 3,192 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Quadrant Capital Group first reported a position in RTO in Q4 2022 and has held it in 13 quarters since. The position peaked at $163K in Q2 2024. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Quadrant Capital Group held 3,192 shares of Rentokil worth $100K as of Q1 2026.
  • Quadrant Capital Group bought 1,362 Rentokil shares in Q1 2026, an estimated $42.9K.
  • Rentokil made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #1481 holding.
  • Quadrant Capital Group first reported a position in Rentokil in Q4 2022 and has held it in 13 quarters since.
  • Quadrant Capital Group's Rentokil position peaked at $163K in Q2 2024.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.